BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yamaguchi H, Taouk GM. A Potential Role of YAP/TAZ in the Interplay Between Metastasis and Metabolic Alterations. Front Oncol 2020;10:928. [PMID: 32596154 DOI: 10.3389/fonc.2020.00928] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 16.5] [Reference Citation Analysis]
Number Citing Articles
1 Cuypers A, Truong AK, Becker LM, Saavedra-garcía P, Carmeliet P. Tumor vessel co-option: The past & the future. Front Oncol 2022;12:965277. [DOI: 10.3389/fonc.2022.965277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wright RHG, Vastolo V, Oliete JQ, Carbonell-caballero J, Beato M. Global signalling network analysis of luminal T47D breast cancer cells in response to progesterone. Front Endocrinol 2022;13:888802. [DOI: 10.3389/fendo.2022.888802] [Reference Citation Analysis]
3 Groza Y, Jemelkova J, Kafkova LR, Maly P, Raska M. IL-6 and its role in IgA nephropathy development. Cytokine Growth Factor Rev 2022;66:1-14. [PMID: 35527168 DOI: 10.1016/j.cytogfr.2022.04.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Thirusangu P, Ray U, Sarkar Bhattacharya S, Oien DB, Jin L, Staub J, Kannan N, Molina JR, Shridhar V. PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma. Oncogene 2022. [PMID: 35804016 DOI: 10.1038/s41388-022-02391-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Kim M, Kim JM, Cho EJ, Sung CO, Kim J, Jang SJ. β-Arrestin 2 suppresses the activation of YAP by promoting LATS kinase activity. Genes & Diseases 2022. [DOI: 10.1016/j.gendis.2022.04.017] [Reference Citation Analysis]
6 Li Y, Yang S, Liu Y, Yang S. Deletion of Trp53 and Rb1 in Ctsk‐expressing cells drives osteosarcoma progression by activating glucose metabolism and YAP signaling. MedComm 2022;3. [DOI: 10.1002/mco2.131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Dai JZ, Wang YJ, Chen CH, Tsai IL, Chao YC, Lin CW. YAP Dictates Mitochondrial Redox Homeostasis to Facilitate Obesity-Associated Breast Cancer Progression. Adv Sci (Weinh) 2022;9:e2103687. [PMID: 35182054 DOI: 10.1002/advs.202103687] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Greer YE, Hernandez L, Fennell EMJ, Voeller D, Chari R, Gilbert S, Tang B, Hafner M, Annunziata CM, Iwanowicz E, Graves LM, Lipkowitz S. Mitochondrial Matrix Protease ClpP Agonists inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis.. [DOI: 10.1101/2022.03.18.484947] [Reference Citation Analysis]
9 Caven LT, Brinkworth AJ, Carabeo RA. Pathogen-driven induction of a host transcriptome facilitating epithelial-to-mesenchymal transition.. [DOI: 10.1101/2022.03.16.484654] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Wnorowski A, Dudzik D, Bernier M, Wójcik J, Keijzers G, Diaz-ruiz A, Mazur K, Zhang Y, Han H, Scheibye-knudsen M, Jozwiak K, Barbas C, Wainer IW. Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased β2 adrenergic agonist. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-07600-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Cunningham R, Hansen CG. The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer. Clin Sci (Lond) 2022;136:197-222. [PMID: 35119068 DOI: 10.1042/CS20201474] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
12 Yun U, Bae S, Song Y, Kim Y. A Critical YAP in Malignancy of HCC Is Regulated by Evodiamine. IJMS 2022;23:1855. [DOI: 10.3390/ijms23031855] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
13 Ortega Á, Vera I, Diaz MP, Navarro C, Rojas M, Torres W, Parra H, Salazar J, Sanctis JB, Bermúdez V. The YAP/TAZ Signaling Pathway in the Tumor Microenvironment and Carcinogenesis: Current Knowledge and Therapeutic Promises. Int J Mol Sci 2021;23:430. [PMID: 35008857 DOI: 10.3390/ijms23010430] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
14 Vigneau AL, Rico C, Boerboom D, Paquet M. Statins downregulate YAP and TAZ and exert anti-cancer effects in canine mammary tumour cells. Vet Comp Oncol 2021. [PMID: 34881506 DOI: 10.1111/vco.12789] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Dietrich C, Hofmann TG. Ferroptosis Meets Cell-Cell Contacts. Cells 2021;10:2462. [PMID: 34572111 DOI: 10.3390/cells10092462] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
16 Matsuda T, Miyata Y, Nakamura Y, Otsubo A, Mukae Y, Harada J, Mitsunari K, Matsuo T, Ohba K, Furusato B, Sakai H. Pathological significance and prognostic role of LATS2 in prostate cancer. Prostate 2021;81:1252-60. [PMID: 34492128 DOI: 10.1002/pros.24226] [Reference Citation Analysis]
17 Ghafouri-Fard S, Azimi T, Hussen BM, Abak A, Taheri M, Dilmaghani NA. Non-coding RNA Activated by DNA Damage: Review of Its Roles in the Carcinogenesis. Front Cell Dev Biol 2021;9:714787. [PMID: 34485302 DOI: 10.3389/fcell.2021.714787] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
18 El-Rashidy AA, El Moshy S, Radwan IA, Rady D, Abbass MMS, Dörfer CE, Fawzy El-Sayed KM. Effect of Polymeric Matrix Stiffness on Osteogenic Differentiation of Mesenchymal Stem/Progenitor Cells: Concise Review. Polymers (Basel) 2021;13:2950. [PMID: 34502988 DOI: 10.3390/polym13172950] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
19 Yi F, Xin L, Feng L. Potential mechanism of circRNA_000585 in cholangiocarcinoma. J Int Med Res 2021;49:3000605211024501. [PMID: 34182814 DOI: 10.1177/03000605211024501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Liu Q, Liu X, Song G. The Hippo Pathway: A Master Regulatory Network Important in Cancer. Cells 2021;10:1416. [PMID: 34200285 DOI: 10.3390/cells10061416] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
21 Kripnerová M, Parmar HS, Šána J, Kopková A, Radová L, Sopper S, Biernacki K, Jedlička J, Kohoutová M, Kuncová J, Peychl J, Rudolf E, Červinka M, Houdek Z, Dvořák P, Houfková K, Pešta M, Tůma Z, Dolejšová M, Tichánek F, Babuška V, Leba M, Slabý O, Hatina J. Complex Interplay of Genes Underlies Invasiveness in Fibrosarcoma Progression Model. J Clin Med 2021;10:2297. [PMID: 34070472 DOI: 10.3390/jcm10112297] [Reference Citation Analysis]
22 Luttman JH, Colemon A, Mayro B, Pendergast AM. Role of the ABL tyrosine kinases in the epithelial-mesenchymal transition and the metastatic cascade. Cell Commun Signal 2021;19:59. [PMID: 34022881 DOI: 10.1186/s12964-021-00739-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
23 Scott KE, Fraley SI, Rangamani P. A spatial model of YAP/TAZ signaling reveals how stiffness, dimensionality, and shape contribute to emergent outcomes. Proc Natl Acad Sci U S A 2021;118:e2021571118. [PMID: 33990464 DOI: 10.1073/pnas.2021571118] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 15.0] [Reference Citation Analysis]
24 Mohajan S, Jaiswal PK, Vatanmakarian M, Yousefi H, Sankaralingam S, Alahari SK, Koul S, Koul HK. Hippo pathway: Regulation, deregulation and potential therapeutic targets in cancer. Cancer Lett 2021;507:112-23. [PMID: 33737002 DOI: 10.1016/j.canlet.2021.03.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 14.0] [Reference Citation Analysis]
25 Di Benedetto G, Parisi S, Russo T, Passaro F. YAP and TAZ Mediators at the Crossroad between Metabolic and Cellular Reprogramming. Metabolites 2021;11:154. [PMID: 33800464 DOI: 10.3390/metabo11030154] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
26 Morales X, Cortés-Domínguez I, Ortiz-de-Solorzano C. Modeling the Mechanobiology of Cancer Cell Migration Using 3D Biomimetic Hydrogels. Gels 2021;7:17. [PMID: 33673091 DOI: 10.3390/gels7010017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
27 Szulzewsky F, Holland EC, Vasioukhin V. YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance. Dev Biol 2021;475:205-21. [PMID: 33428889 DOI: 10.1016/j.ydbio.2020.12.018] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 24.0] [Reference Citation Analysis]
28 Crosby K, Wood AW, Simendinger J, Grange C, Carr L, Costa-Grant K, Roller CJ, Polakiewicz RD. YAP vs. TAZ: differences in expression revealed through rigorous validation of target-specific monoclonal antibodies. J Histotechnol 2020;43:182-95. [PMID: 33245266 DOI: 10.1080/01478885.2020.1847012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Wright RHG, Vastolo V, Oliete JQ, Carbonell-caballero J, Beato M. Signalling Network of Breast Cancer Cells in Response to Progesterone.. [DOI: 10.1101/2020.11.03.366401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Scott KE, Fraley SI, Rangamani P. Transfer function for YAP/TAZ nuclear translocation revealed through spatial systems modeling.. [DOI: 10.1101/2020.10.14.340349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]